The most common and frustrating side effect in cancer therapy is the medication-induced fatigue. Patients with multiple myeloma and mantle cell lymphoma as well as other blood malignancies using Lenalidomide often describe a state of chronic fatigue and weakness. This fatigue can have repercussions on several aspects of one’s life, including one ability to work,…